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Summary 
Natural killer (NK) cells that express the NKB1 receptor are inhibited from killing target cells 
that possess human histocompatibility leukocyte antigen (HLA) B molecules bearing the Bw4 
serological epitope. To investigate whether NKB1 expression is affected by HLA type, periph- 
eral blood lymphocytes of 203 HLA-typed donors were examined. Most donors had a single 
population ofNKB1 + cells, but some had two populations expressing different cell surface lev- 
els of NKB 1, and others had no detectable NKB 1  + cells. Among the donors expressing NKB 1, 
both the relative abundance of NKB 1  + NK cells and their level of  cell surface expression varied 
substantially.  The percentage of NKB1 + NK cells ranged from 0 to >75% (mean 14.7%),  and 
the mean fluorescence of the positive population varied over three orders of magnitude.  For 
each donor, the small percentage ofT cells expressing NKB1  (usually  <2%), had a pattern of 
expression mirroring that of the NK cells. NKB1 expression by NK and T  cells remained stable 
over the 2-yr period that five donors were tested. Patterns of NKB1 expression were not asso- 
ciated with Bw4 or Bw6 serotype of the donor or with the presence of any individual HLA-A 
or -B antigens. Cells expressing NKB 1 are often found in donors who do not possess an appro- 
priate class I ligand, and can be absent in those who express Bw4  + HLA-B antigens.  Family 
studies further suggested that the phenotype of NKB1  expression is inherited but not HLA 
linked. Whereas identical twins show matching patterns of NKB 1 expression, HLA-identical 
siblings  can differ in NKB1 expression, and conversely, HLA-disparate siblings  can be similar. 
Thus NKB1 expression phenotypes are tightly regulated and extremely heterogenous, but not 
correlated with HLA type. 
N 
K cells kill a variety of neoplastic and virally infected 
target  cells  without  prior  sensitization  (1).  Unlike 
most CTL, lysis of target cells by NK cells does not require 
presentation of an antigen by class I or II MHC molecules. 
Instead, target cell lysis is controlled by a number of novel 
receptors that either stimulate or inhibit cytolytic function 
(2-5). Cellular ligands recognized by the stimulatory recep- 
tors are as yet unidentified. It is clear, however, that the in- 
hibitory receptors recognize polymorphic determinants of 
MHC class I molecules (6).  Thus NK cells kill target cells 
that lack class I antigens, but expression of certain class I al- 
lotypes can protect a target cell from lysis (7, 8). K~irre et al. 
(9) have postulated that the inhibitory effect of class I mol- 
ecules on NK cells allows them to complement the role of 
CTL in immune surveillance, by detecting and eliminating 
cells with reduced expression of class I  due to viral infec- 
tion or malignant transformation. 
Nine different cDNAs encoding human NK cell class I 
receptors have been identified (3-5).  One of these recep- 
tors, NKB1, is recognized by the DX9 mAb (10). NK cells 
that express NKB 1 demonstrate reduced lysis of target cells 
that  express HLA-B antigens  having the  Bw4  serological 
epitope (11). HLA-B allotypes possess either Bw4 or its al- 
ternative, the Bw6 epitope (12).  Certain HLA-A allotypes 
also  possess the Bw4 epitope. Thus, each individual is ei- 
ther homozygous or heterozygous with regard to HLA-B 
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or two Bw4 + HLA-A antigens. 
Preliminary analysis showed that  the percentage of NK 
cells that express NKB1 varied among the individuals tested 
(10). Heterogeneity in expression of murine NK cell class I 
receptors has been observed among inbred mouse strains of 
different  MHC  types  (13).  Additionally,  the  expression 
level of one  murine  receptor,  Ly-49A, was influenced by 
the presence of a class I MHC  antigen that acts as a ligand 
(14).  Thus,  in mice it appears that MHC  type may influ- 
ence  the types and/or levels of class I  receptors expressed 
by NK cells. The present study was undertaken to investi- 
gate the heterogeneity in NKB1  expression among differ- 
ent individuals and its relationship to HLA type. 
Materials  and  Methods 
Flow Cytometry and mAbs.  The anti-NKB1 mAb, DX9  (10), 
was conjugated to phycoerythrin. Anti-CD3 (Leu 4) was conju- 
gated to Cy-Chrome (PharMingen, San Diego, CA). Anti-CD56 
(L185) was provided generously by Becton Dickinson Immuno- 
cytometry Systems (San Jose, CA), and was conjugated to FITC 
as described (15). For flow cytometric analysis, mononuclear cells 
from  the  peripheral blood of healthy donors  were  isolated by 
density centrifugation with Ficoll-Hypaque (Pharmacia/LKB, Pis- 
cataway, NJ). PBMC were divided into two aliquots and stained 
with the three antibody conjugates described above, or isotype- 
matched control antibody conjugates, as described (15).  Analysis 
was performed on a FACScan  |  flow cytometer (Becton Dickin- 
son). Forward and side light scatter gates were set to identify the 
lymphocyte population. NKB1  expression, as measured by DX9 
mAb  staining,  was  then  analyzed separately for  NK  (CD56 +, 
CD3-) and T  cell (CD3 +) populations. 
Preparation of NK Cell Clones.  PBMC  from  a  single  healthy 
adult who possessed  a bimodal population of NKB1 + cells were 
isolated and stained as described above. NK cells (CD56 +, CD3-) 
that expressed either low levels of NKB1, high levels of NKB1, 
or did not express NKBI, were cloned at one cell per well using a 
single cell deposition system of the FACStar  PLUs|  flow cytometer 
(Becton  Dickinson).  Clones  were  established by  using  culture 
conditions described previously (16). All clones generated by this 
procedure had the  cell surface phenotype  CD3-,  CD56 +,  and 
mediated NK cytolytic function. 
Preparation of F(ab ')e and Fab Fragments of DX9 mAb, and NKB I 
Binding Experiments.  F(ab')2 and  Fab fragments were  prepared 
by digesting DX9  lgG with immobilized pepsin or papain, re- 
spectively (10 mg/ml in 10 ml of 0.2 M  sodium citrate, 0.15 M 
NaC1 buffer, pH 3.5, with 2.5 ml immobilized pepsin for 2 h  at 
37~  (Pierce Chemical Co., Rockford, IL).  Fc-containing spe- 
cies were  then removed by protein A  affinity chromatography. 
F(ab')2 and  Fab  fragment preparations were  determined  to  be 
pure by SDS-PAGE analysis. To compare the affinity of DX9 for 
the  molecules expressed by NKB1  bright and  dim clones,  106 
cells of four NKB1  bright and four NKB1  dim NK cell clones 
were incubated on ice for 45 min with 10 nmol DX9 F(abr  and 
Fab fragments, in a volume of 100  pJ.  The  samples were then 
washed with 3 ml PBS containing 0.01% NAN3. The cells were 
stained with F(ab')2 of goat lg, specific for the F(ab')2 fragment of 
mouse Ig, conjugated to fluorescein (Jackson  lmmunoKesearch 
Laboratories Inc.,  West  Grove,  PA),  washed  with  3  ml  PBS/ 
NaN 3 containing propidium iodide,  and  resuspended in  1  ml 
PBS/NaN3. Samples were incubated on ice until analysis using a 
FACScan  |  flow cytometer. Thereafter, the cells were incubated 
at room temperature, and reanalyzed at the specified time inter- 
vals  after initial analysis.  For titration of DX9  mAb binding to 
NKB1 bright and dim clones, 106 cells were incubated with the 
following quantities of DX9  F(ab')2: 500,  250,  1.25, 62.5,  31.3, 
15.6,  and 0 ng in 100 pJ PBS/NaN  3. Staining was carried out as 
described above, and the samples were analyzed immediately by 
flow cytometry. 
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Figure 1.  FACS  |  histograms showing DX9 antibody binding to NK 
cells of three peripheral blood donors. The lymphocyte population was 
isolated by setting forward and sidelight scatter gates, then gates were set 
to display DX9 staining of NK cells (CD3-, CD56+). Peaks under the 
bars represent the populations of cells that stain positively for NKB1. Un- 
marked peaks (left) are NK cells that do not stain for NKB1. The mean 
fluorescence intensity of the positive populations is given in arbitrary flu- 
orescence units. Percentage values indicate the proportion of the total NK 
cell population contained within the NKB1 + population. 
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bright and two NKB1 dim NK cell clones were expanded to 40- 
100  X  106 cells, and labeled with 12sI using lactoperoxidase/glu- 
cose oxidase.  Cells were  lysed in  Tris-huffered saline  (50  mM 
Tris, 15 mM NaC1,  pH 8.0),  containing 1% NP-40 and protease 
inhibitors (1 mM PMSF and 20 U/ml aprofinin). NKB1 antigen 
was  immunoprecipitated as  described previously (10).  Samples 
were analyzed by SDS-PAGE on a 10% gel. 
Cell-mediated Cytotoxidty.  Cell killing was measured by using 
a standard 4-h SlCr radioisotope-release assay (17).  Percent lysis 
was calculated by the formula: [(Experimental cpm -  spontane- 
ous cpm)/(TotaI cpm  -  spontaneous cpm)]  X  100  =  % lysis. 
The HLA class I-negative lymphoblastoid cell line 721,221  (18) 
and transfectants of this line expressing individual class I aUotypes, 
were  used  as  target  cells.  Transfectants  were  generated  as  de- 
scribed (11). The DX9 mAb was added where specified to a final 
concentration of 6.7 p,g/ml. Assays were performed in duplicate 
or triplicate, and were repeated two to three times for each clone. 
Serological Class I HLA Typing.  Serologic typing for all HLA 
class I  antigens was performed using a  complement-dependent, 
fluorochromasia, microcytotoxicity technique. Frozen PBL were 
used directly after relayering over a Ficoll-Hypaque gradient and 
staining with  carboxy-fluorescein diacetate (C-FDA; Molecular 
Probes  Inc.,  Eugene,  OR_) yielding original viabilities of 99%. 
Sera and cells were incubated at 22~  for 30 man; rabbit comple- 
ment was then added and the trays were incubated an additional 
90 man.  288 sera obtained by international exchange and cover- 
ing all specificities with the exception of A43 (an antigen found 
only in South African Blacks) were used for each typing. 
Results 
Heterogeneity  in NKB1 Expression.  To  assess NKB1  ex- 
pression by PBL,  we  used flow cytometric analysis. Anti- 
CD3  and anti-CD56  antibodies were  used to differentiate 
the three types oflymphocytes (T, NK, and B  cells). Thus, 
T  cells stained positively for CD3,  NK  cells were  CD3- 
and  CD56 +, and B  cells were  double negative. The DX9 
mAb  was  used  to  investigate  NKB1  expression  by  each 
type  of lymphocyte.  Only  NK  and  T  cell  populations 
stained specifically for NKB1. Three patterns of NKB1  ex- 
pression were observed. Some donors bad a unimodal dis- 
tribution ofNKB1 + cells (Fig. 1, a and b), others had a bi- 
modal  distribution  consisting of two  distinct populations 
differing in fluorescence intensity (Fig. 1 c), and the rest had 
no detectable NKB1 + cells (data not shown). 
To investigate the stability of NKB1  expression by PBL, 
we analyzed frozen and fresh PBMC  samples drawn from 
five donors over a 2-yr period (Table  1).  For each donor, 
the percentage of NK cells that expressed NKB 1 and their 
mean fluorescence intensity remained remarkably constant. 
Donors who possessed either a unimodal or bimodal distri- 
bution of NKB1 + cells maintained the phenotype. To ex- 
amine further  the  stability of NKB1  expression,  NK  cells 
were cloned from the bright, dim, and NKBl-negative cell 
populations of the bimodal donor  (Fig.  1 c). NK cells that 
did not express NKB1  at the time of sorting remained neg- 
ative in culture, and those with dim or bright NKB1  stain- 
ing maintained these phenotypes when  assayed repeatedly 
during 2 mo of growth in culture (data not shown). 
The differences in NKB1  staining intensity among indi- 
viduals could be due to variations in the level of expression 
of NKB1  at the cell surface, or to expression ofisoforms of 
NKB1  with different affinities for the DX9  mAb.  To  ad- 
dress this question, the rates of dissociation ofDX9  F(ab')2 
and  Fab  fragments  bound  to  cells of the  dim  and  bright 
Table 1.  Stability q( NK and T Cell NKB1 Expression 
Percent NKB 1 +  Percent NKB 1  + 
Donor  Sample  Date  NK cells  MFI  T cells  MFI 
1  Frozen PBMC  19/2/93  51.1  756  13.1  475 
1  Fresh PBMC  5/1/95  47.5  781  8.0  483 
2  Frozen PBMC  19/2/93  16.5  325  2.3  233 
2  Fresh PBMC  5/1/95  17.7  342  0.8  267 
3  Frozen PBMC  9/9/94  7.9  118  0.4  109 
3  Frozen PBMC  16/9/94  7.8  124  0.2  88 
3  Frozen PBMC  29/9/94  7.2  119  0.3  127 
3  Frozen PBMC  30/9/94  7.3  125  0.3  105 
4  Frozen PBMC  19/2/93  5.0, 6.0  159, 538  2.9  136, 402 
4  Fresh PBMC  5/1/95  5.4, 7.5  174, 600  1.4  164, 503 
5  Frozen PBMC  19/2/93  23.1  335  1.1  272 
5  Frozen PBMC  23/6/94  26.0  357  0.8  293 
5  Frozen PBMC  7/7/94  23.9  352  0.5  297 
Results  of flow cytometric  analysis of NKB1  expression by lymphocytes from  peripheral blood samples collected over a 2-yr period.  Percent 
NKB 1  + NK and NKB 1  + T cells represent the percentage of the total NK or T cell population that stained positively for NKB 1. Mean fluorescence 
staining intensity (MFI) of the positive population is given in arbitrary fluorescence units. Two percentage and fluorescence values are shown for do- 
nors with a bimodal distribution ofNKB1 + cells, representing the dim and bright populations. All samples were analyzed in the same experiment. 
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Figure 2.  (a) The percentage of NK cells expressing NKBI is not cor- 
related with its expression level among unrelated donors. The NKB1 ex- 
pression levels and the relative frequency of NKB1 expression both form 
broad distributions ofphenotypes, without evidence of clustering. (b) NK 
and T cell NKB1 expression levels correlate well for each donor￿9 Each 
plot represents a set of peripheral blood samples from unrelated donors, 
analyzed in a single experiment. Samples displaying a bimodal phenotype 
of NKB 1 expression were excluded from the analyses. Other sets of sam- 
ples gave similar distributions. 
clonal  cultures  were  compared.  Were  the  difference  in 
staining intensity of the two types of clones due to DX9 af- 
finity  differences,  then  the  monovalent  Fab  fragment 
would dissociate  faster  than the  divalent  F(ab')2 fragment. 
This was not observed;  F(ab')2 and Fab fragments dissoci- 
ated  with  similar  kinetics  from clones  staining brightly or 
dimly for NKB1  (data not shown).  Furthermore,  titration 
of DX9  F(ab')2 binding  to  NKB1  dim  and  bright  clonal 
cultures  demonstrated  nearly  identical  curves,  consistent 
with  a  similar  avidity  of DX9  binding  for  both  types  of 
NKB1 + cell (data not shown). NKB1  immunoprecipitated 
from radiolabeled NKB1 bright and dim clones had match- 
ing mobility by SDS-PAGE, indicating they are the  same 
molecular size  (data  not shown).  Thus,  differences  in  the 
fluorescence staining intensity of NK cell populations with 
the  DX9  mAb  appear  to  result  from  quantitative  differ- 
ences in the level of cell surface expression of NKB1 mole- 
cules. 
Cytolysis by NK Cell Clones Expressing Low or High Levels 
of NKB1.  NK cells cloned from the NKB1 dim and bright 
populations of a donor with the bimodaA NKB1 phenotype 
were tested for their ability to kill 721.221  target cells ex- 
pressing HLA-B*5101 or B'5801  (both Bw4 +) as the only 
class I antigen. Both NKB1  dim and bright clones showed 
diminished lysis of the B'5101 and B'5801 transfected tar- 
get cells,  in comparison with the untransfected 721.221 cell 
line  (data not shown).  In each  case,  addition  of the  DX9 
mAb prevented the inhibitory effect ofB'5101 and B'5801 
expression, demonstrating that the inhibition was due to an 
interaction  with  NKB1.  Thus,  NK  cells  with  different 
NKB1  expression  levels  nevertheless  have  similar  inhibi- 
tory specificity for Bw4 + HLA-B antigens. 
Relationship of NKB1 Expression to HLA Type.  To inves- 
tigate the relationship between NKB1 expression and HLA 
type,  blood  samples  from  164  unrelated  donors,  and  39 
members of nine families were examined. All donors were 
serologically typed for HLA-A, -B,  and  -C  antigens,  and 
haplotypes  were  assigned for the  family  members.  In the 
first sampling of 69 donors, comparable numbers of HLA-B 
Bw4  homozygous  (n  =  21),  Bw4/6  heterozygous  (n  = 
27), and Bw6 homozygous (n =  21) individuals were cho- 
sen. Within this population,  47 donors (68.1%)  had a uni- 
modal distribution ofNKB1 § NK cells,  12 donors (17.4%) 
had a bimodal phenotype,  and  10  donors  (14.5%)  had no 
detectable NKB1 expression. 
The level of NKB1  cell surface expression and the rela- 
tive  abundance  of NK cells expressing NKB1  appeared  to 
be unrelated traits. Fluorescence intensity of NKB1 staining 
showed no correlation with the percentage ofNKB1 §  NK 
cells  present  in  the  sample  (Fig.  2  a).  Both  traits  showed 
significant polymorphism, varying as an essentially continu- 
ous gradation that did not cluster into distinct  subpopula- 
tions  (Fig.  2  a).  The  NKB1  fluorescence  intensity  of NK 
cells  correlated well with  that  of NKB1 + T  cells  for each 
donor (Fig.  2  b).  However, no correlation of the percent- 
age  of NKB1 +  NK  cells  with  that  of T  cells  expressing 
NKB1 was observed (data not shown). 
No  association  of Bw4/Bw6  serotype  with  either  the 
percentage  of NK cells  expressing NKB1,  or with NKB1 
expression level, was found for the donors in this sampling. 
An equally broad distribution  of NKB1 +  percentages  and 
NKB1 staining intensities  was seen for Bw4 homozygotes, 
Bw4/6 heterozygotes, and Bw6 homozygotes (Fig. 3, a and 
b).  Samples with the unimodal,  bimodal,  and undetectable 
phenotypes  of NKB1  expression were  also evenly distrib- 
uted among the three serotypes (data not shown). 
Polymorphisms  at  positions  77-83  of the  class  I  heavy 
chain determine  Bw4 and Bw6 serological reactivity  (12). 
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Figure 3.  Phenotypes of  NKB1 expression do not correlate with HLA-Bw4/Bw6 serotype. (a) The percentage of  NK cells expressing NKB1 in a pop- 
ulation of unrelated peripheral blood donors, divided according to Bw4/Bw6 serotype. For each group of donors, the mean and standard deviation is as 
follows: Bw4 homozygous 13.4 -  10.6; Bw4/6 heterozygous 12.0 + 9.7; Bw6 homozygous 12.5 + 8.4. (b) The mean fluorescence intensity of  NK cell 
NKB1 staining of samples from a population of unrelated peripheral blood donors, divided according to Bw4/Bw6 serotype. The mean of each data set 
is shown as a horizontal bar. Mean and standard deviation values are as follows:  Bw4 homozygous  411 +- 285; Bw4/6 heterozygous 412 -+ 256; Bw6 ho- 
mozygous 397 -  276. Mean fluorescence intensity is given in arbitrary fluorescence units. Samples displaying a bimodal phenotype of NKB1 expression 
are not included in these analyses. 
Bw4 + class  I allotypes possess one of five related sequence 
motifs within this region.  Cella et al.  (19)  have found that 
certain NK cells  are more effectively inhibited by HLA-B 
antigens possessing a Bw4 motif with isoleucine at position 
80.  To  determine  whether  NKB1  expression  correlates 
with individual Bw4 motifs, we analyzed our data accord- 
ing to the amino acid motifs likely to be present at the Bw4 
or  Bw6  serological  epitopes  of the  HLA-B  antigens  ex- 
pressed by each donor. No correlation of NKB1 expression 
with the presence or absence of any Bw4 motif was found. 
Likewise,  the  percentage  of NKB1 +  cells  and  NKB1  ex- 
pression  level  showed  no  association  with  any  individual 
HLA-B or -A antigen  expressed in this population of do- 
nors (data not shown). 
HLA allotypes for which an inhibitory effect on NKB1 + 
NK cells has been demonstrated include B*1513, B'2705, 
B'5101, and B'5801  (11). Whether HLA-B antigens with 
an alternative  Bw4 motif such as B44,  and Bw4 +  HLA-A 
antigens  such  as  A24  and  A25,  mediate  inhibition  by 
NKB1 is less clear (11,  19). To investigate the effect of the 
presence of potential class I ligands on NKB1  expression, a 
set of 90 donors who possessed a single Bw4 + HLA-A or -B 
allotype was selected, and the expression of NKB1 by their 
NK and T  cells  examined.  The test antigens  expressed by 
donors in this group were HLA-A24, A32, B38, B44, B51, 
and B58. Again, the number of cells  expressing NKB1 and 
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their levels of expression showed a wide-ranging and con- 
tinuous distribution.  The heterogeneity of both parameters 
was similar  to that  observed within  the set of Bw4/Bw6-- 
serotyped donors (Fig. 3, a and b).  None of the three phe- 
notypes of NKB1  expression  (unimodal, bimodal, and un- 
detectable)  appeared  to  be  preferentially  associated  with 
any  of the  test  antigens.  From  these  analyses,  NKB1  ex- 
pression cannot readily be correlated with Bw4/Bw6 sero- 
type or with any individual HLA-A or -B antigens. 
NKB1 Expression by Related Individuals.  To  investigate 
the  genetics  of NKB1  expression,  we  analyzed  samples 
from 39 members of nine families. The samples included 4 
pairs of monozygotic identical twins, 6 pairs of class I HLA- 
identical siblings, and 13 pairs of siblings who had unrelated 
class I HLA haplotypes (Table 2). The pairs oft-wins all had 
the  unimodal  phenotype  of NKB1  expression.  For  each 
twin  both  the  percentage  of NKB1 +  NK  cells  and  the 
mean fluorescence intensity values were within 20% of the 
average of the two samples. In contrast, only one of the six 
pairs of HLA-identical siblings showed such similar patterns 
of NKB1  expression.  For  the  five  other  pairs,  four  con- 
sisted of one unimodal and one bimodal sibling,  and in the 
remaining  pair,  one  sibling  lacked  NKB1 +  NK  cells 
whereas  the  other  had  a  detectable  unimodal  population 
(Table 2). Among the 13 pairs of HLA-disparate siblings, 4 
pairs had similar NKB1 fluorescence intensities,  but only 2 Table 2.  NKB1 Expression by Pairs of Identical Twins,  Class I HLA-identical and-disparate  Siblings 
Sibling  Percent NKB1 +  NK cell NKB1  Percent NKB1 +  T  cell NKB1 
Relationship  pair  Sample  NK cells  MFI  T  cells  MFI 
Identical twins  1  C1  11.5  252  0.3  220 
C2  9.1  232  0.4  218 
2  G1  17.4  750  0.2  633 
G2  12.4  865  0.3  831 
3  H1  8.8  77  0.1  61 
H2  6.5  66  0.1  67 
4  K2  10.1  684  0.2  490 
K3  14.4  448  1.4  384 
HLA-identical siblings  1  A3  18.8  526  2. ]  366 
A5  4.9, 9.4  108, 421  2.1  96, 375 
2  B1  3.4, 6.4  115, 594  1.0  110, 575 
B4  2.2  491  0.2  312 
3  B2  7.7  92  0.1  70 
B5  5.7  83  0.1  54 
4  D3  0  0  0  0 
D4  5.0  311  0.3  371 
5  F2  2.5, 4.5  72, 415  1.0  58, 300 
F4  4.5  113  0.4  93 
6  F5  7.4, 9.9  155, 502  0.2  177, 348 
F7  14.0  516  <0.1  ND 
HLA-disparate siblings  1  A3  18.8  526  2.1  366 
A4  34.2  469  0.9  315 
2  A4  34.2  469  0.9  315 
A5  4.9, 9.4  108, 421  2.1  96, 375 
3  B1  3.4, 6.4  115, 594  1.0  110, 575 
B2  7.7  92  0.1  70 
4  B1  3.4, 6.4  115, 594  1.0  110, 575 
B5  5.7  83  0.1  54 
5  B2  7.7  92  0. I  70 
B4  2.2  491  0.2  312 
6  B4  2.2  491  0.2  312 
B5  5.7  83  0.1  54 
7  E1  38.9  585  2.3  364 
E3  34.8  522  1.4  317 
8  F5  7.4, 9.9  155, 502  0.2  177, 348 
F6  0  0  0  0 
9  F6  0  0  0  0 
F7  14.0  516  <0.1  ND 
10  H1  8.8  77  0.1  61 
H4  0  0  <0.1  ND 
11  H2  6.5  66  0.l  67 
H4  0  0  <0.1  ND 
12  K1  16.8  450  7.2  305 
K2  10.1  684  0.2  490 
13  K1  16.8  450  7.2  305 
K3  14.4  448  1.4  384 
Results of flow cytometric analysis of NKB1 expression by lymphocytes from peripheral blood samples of related donors. Present NKB1 + NK and 
NKB i + T cells represent the percentage of the total NK or T cell population that stained positively for NKB 1. Mean fluorescence staining intensity 
(MFI) of the positive population is given in arbitrary fluorescence units. Two percentage and fluorescence values are shown for donors with a bimo- 
dal distribution of NKB 1  + cells, representing the dim and bright populations. All samples were analyzed in the same experiment. of  these pairs were also similar in the percentage of NKB1 + 
cells.  These  observations  suggest  that  NKB1  expression 
phenotypes are determined genetically, but are not MHC 
linked. 
Evidence from four informative families further indicates 
inheritance ofNKB1 phenotype. The frequency ofNKB1 + 
NK cells and their cell surface expression levels for MHC- 
haplotyped family members are shown in Fig.  4,  a-d.  The 
percentage  of cells  expressing NKB1  segregates  indepen- 
dendy from NKB1 expression level (Fig.  4, a-c). Children 
usually have NKB1 expression levels similar to one parent, 
however the percentage of NKB1 + NK cells can be inter- 
mediate between those of the parents, or greater than ei- 
ther parent (Fig. 4, a-c). Neither the percentage ofNKB1 + 
cells, nor the cell surface expression level of NKB1 segre- 
gates with MHC haplotype (Fig. 4, a-d). 
Discussion 
K~irre and co-workers (9,  20) have postulated that NK 
cells specifically lyse target cells  that lack self-class  I  anti- 
gens. According to this hypothesis, the repertoire of recep- 
tors expressed by NK cells should be biased towards those 
recognizing determinants presented by self-class  I antigens. 
NK  cells  might  therefore undergo  a  selection process in 
which only developing cells  expressing receptors with af- 
finity for self-antigens are allowed to mature, as is postu- 
lated for T  cells. This study was undertaken to investigate 
whether heterogeneity in expression of NKB1, an inhibi- 
tory class I receptor of known HLA specificity, showed ev- 
idence of such an NK cell "education" process relating to 
class I antigens. 
NKB1 recognizes HLA-B antigens that express the Bw4 
serological epitope. In our population of unrelated donors, 
neither the percentage of NKB1 + cells, nor NKB1 expres- 
sion levels, was associated with Bw4 or Bw6 serotype, or 
with expression of any individual HLA-A or -B antigens. 
Furthermore, in family studies, no hnkage of NKB1 phe- 
notype with MHC haplotype was observed. Cells express- 
ing NKB1 were often found in donors who do not possess 
a known class I hgand,  and could be absent in those who 
express Bw4 + HLA-B antigens. Thus we find no evidence 
for determination of NKB1 expression by donor HLA type. 
This contrasts with studies demonstrating an influence of 
MHC  class  I  antigens  on  expression  of murine  NK  cell 
class I receptors (14, 21, 22). Ly-49A is an inhibitory recep- 
tor with specificity for H-2D  d and H-2D  k allotypes (23- 
25).  Experiments with bone marrow chimeras and trans- 
genic  mice  provide evidence for a  role  of class  I  MHC 
antigens  in modulating Ly-49 expression (14,  21).  Com- 
pared with nonchimeric and nontransgenic mice, those in 
which a potential class I ligand for the Ly-49A receptor had 
been introduced showed reduced levels of Ly-49A cell sur- 
face expression, but the percentage of NK cells bearing Ly- 
49A was  unchanged  (14,  21).  In our analysis,  there is no 
significant difference in the mean fluorescence intensity of 
NKB1  staining among Bw4 homozygous or heterozygous 
donors  compared with  Bw6  homozygous  donors.  Thus, 
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we  see  no  simple  correlation of NKB1  expression level 
with the presence of a potential class I  ligand.  However, 
further studies will be required to assess whether the sub- 
stantial  heterogeneity  of NKB1  expression  levels  within 
donor populations, and the presence of cells with two dis- 
tinct levels of NKB1  expression in certain individuals, are 
related to functional differences in the degree of inhibition 
mediated by NKB1. 
Similar to our finding that Bw6 homozygous donors can 
express NKB1, mouse strains that do not express H-2D  a or 
H-2D  k can  express significant numbers  of Ly-49A  +  NK 
cells (13,  22). Therefore, in both species, expression of re- 
ceptors for which  there  is  no  class I  hgand  is permitted. 
One explanation for this might be that the receptors recog- 
nize other ligand(s)  in addition to class I molecules, and se- 
lection is based on these alternative interactions. However, 
our findings are also consistent with the possibility that in- 
hibition of NK cells by self-MHC antigens is governed by 
a stochastic process, whereby a  developing NK cell must 
express at least  one receptor that mediates inhibition by a 
self-class  I allotype, but expression of other receptors is not 
prohibited.  Selection of NK cells may therefore be based 
on the constellation of receptors expressed, rather than on 
expression of any individual receptor. Testing this possibil- 
ity will require functional and molecular assessment  of all 
class I receptors expressed by NK cells from individuals of 
known HLA type. 
Our results suggest NKB1 expression by NK and T  cells 
is genetically controlled. Among unrelated individuals, two 
parameters  of NKB1  expression vary:  the  relative  abun- 
dance of cells bearing NKB1, and the level of NKB1  cell 
surface expression. In our population of unrelated donors, 
substantial  heterogeneity was  present in both NKB1  fre- 
quency and expression level, but no  correlation between 
the traits was seen within the donor population, suggesting 
they are independent parameters. Within families,  the two 
characteristics segregated independently, further indicating 
that they are separate traits.  Within an individual, both pa- 
rameters  remained  very  stable  over  time,  and  identical 
twins had similar phenotypes for both, whereas both HLA- 
identical and  -disparate  sibhngs  were usually dissimilar  in 
NKB1 expression phenotype. This suggests  the phenotype 
is probably genetically, rather than environmentally deter- 
mined.  We  also  saw  no  correlation of NKB1  expression 
pattern with the sex of the donor. Thus, the level and fre- 
quency  of NKB1  expression  appear  to  be  independent 
traits, hkely governed by autosomal genes. 
The  degree  of heterogeneity  observed  for  both  traits 
within  the  population  of unrelated  donors  is  surprising. 
The diversity of phenotypes could be explained by poly- 
morphism ofthe molecules reactive with the DX9  mAb. 
Human NK cell class I receptors are members of the Ig su- 
perfamily. Two types of human inhibitory class I receptors 
have been identified: the p58 family, which has two extra- 
cellular  Ig  domains,  and  the  p70  molecules,  which  has 
three Ig domains (3, 4). NKB1 belongs to this latter group 
(5).  Complementary DNA  encoding four p70  molecules 
and six members of the p58 family has been identified (3, 4, Family  "A" 
A2 B60 Cw3 
A1 B7 Cw7 
25.6% 
442 mfl 
A2 B60  Cw3 a 
A2 B8 Cw7 
18.8 % 
526 mfl 
A1 B7 Cw7 
A2. B27 Cwl 
34.2 % 
469 mfl 
A2 B8 Cw7 
C 
A2 B27 Cwl 
2.2%,  18.4% 
108, 430 mfl 
A2 B60 Cw3 a 
A2 B8 Cw7 
4.9%, 9.4% 
108, 421  mfl 
Family  "B" 
A2 B7 Cw7 
a 
A2 B27 Cw2 
5.2%, 5.9% 
140, 579 mfl 
A3 B57 Cw6 
C 
A24 B63 Cw3 
0.9% 
64 mfl 
A2 B7 Cw7  A2 B27 Cw2  A2 B7 Cw7  A2 B7 Cw7  A2 B27 Cw2 
a  b  a  a  b 
c  d  d  c  d 
A3 B57 Cw6  A24 B63 Cw3  A24 B63 Cw3  A3 B57 Cw6  A24 B63 Cw3 
3.4%, 6.4%  7.7%  12.7%  2.2%  5.7% 
115, 594 mfl  92 mfl  87 mfl  491  mfl  83 mfl 
26). The two- and three-Ig domain-type receptors appear 
to be products of different genes (3-5), however it is not 
clear whether different cDNA sequences within each fam- 
ily are allelic products of a single locus or derive from dis- 
tinct gene loci. The DX9 mAb reactivity of PBL samples 
may therefore appear heterogenous because different indi- 
viduals may express different numbers of related receptors 
that share the DX9 epitope. 
However, dim and bright NKB1 + NK cell clones from a 
single  individual  analyzed in this study,  and  NKB1 +  NK 
cell clones from unrelated donors tested in previous investi- 
gations  (10,  11),  have  similar  functional  specificities  for 
Bw4 +  HLA-B  antigens.  Furthermore,  investigation  of 
DX9 Fab and F(ab')2 binding to NKB1  molecules of dim 
and bright NK cell clonal populations revealed no affinity 
differences, and immunoprecipitated protein had identical 
mobility by SDS-PAGE. Therefore the phenotypic hetero- 
geneity is likely to indicate true variations in the level of 
expression of one or a few NKBl-like receptors. If so, the 
diversity might be explained by regulation of NKB1 genes 
by  other  genetic  or  epigenetic  factors,  which  produce 
subtle variations in the frequency and level of NKB1  ex- 
pression. Phenotypic heterogeneity observed among indi- 
viduals  in  expression of the  complement regulatory pro- 
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A33 B14 Cw8  a 
A68 B14 Cw8 
0.0% 
0 mfl 
A33 B14 Cw8 
C 
A33 B14 Cw8 
12.3% 
387 mfl 
A68 B14 Cw8 
b 
cord 
A33 B14 Cw8 
0.0% 
0 mfl 
A68 B14 Cw8 
A33 B14 Cw8 
5.0% 
311  mfl 
b 
cord 
A29 B35 Cw4 
a 
A26 B38 Cw- 
4.6%, 24.9% 
1 14, 499 mfl 
I 
I 
A29 B35 Cw4 
a 
A26 B7 Cw7 
16.1% 
131  mfl 
Family  "F" 
￿9 
All B50 Cw6 
C 
A2 B44 Cw- 
A29 B35 Cw4  A29 B35 Cw4  A29 B35 Cw4  A26 B7 Cw7  A29 B35 Cw4 
a  a  a  b  a 
d  d  c  d  c 
A2 B44 Cw-  A2 B44 Cw-  A11 B50 Cw6 
2.5%, 4.5%  4.5%  7.4%, 9.9% 
72,415 mfl  113 mfl  155, 502 mfl 
A2 B44 Cw-  A11 B50 Cw6 
0.0%  14.0% 
0 mfl  516 mfl 
Figure  4.  a-d.  Pedigrees 
showing the class I HLA haplo- 
types and phenotypes of NKB1 
expression. HLA class [  haplo- 
types are represented by labeled 
parallel bars (a-d). Percent values 
indicate  the  proportion  of the 
total NK cell population that ex- 
presses  NKB1.  Mean  fluores- 
cence  intensity  of  NK  cell 
NKB1 staining in arbitrary fluo- 
rescence  units  is  given  below 
these values. Single values indi- 
cate a  unimodal  distribution  of 
NKB1  staining, whereas two 
values indicate a bimodal distri- 
btltion. 
tein,  C4b-binding protein,  may be  determined in  such  a 
manner (27). 
Also unexpected was the finding that two distinct popu- 
lations of NKB 1 + cells could be present in a single individ- 
ual. Studies ofmurine NK cell class I receptors indicate that 
expression  of a  given receptor may be  influenced  by the 
presence of another allele at the same locus. Held et al. (28) 
have found evidence for mutual exclusion of alleles for two 
members  of the  murine  Ly-49  family,  Ly-49A  and  Ly- 
49C. Thus the number of receptors expressed by individual 
murine NK cells may be limited, and expression of distinct 
receptors  regulated  coordinately  within  the  cell.  Such  a 
process could explain our observation that certain individu- 
als  possess a  bimodal distribution  of NKB1 +  NK  cells, if 
NKBI  expression level can be affected by the presence of 
other  class  I  receptors  expressed  by  a  proportion  of the 
NKB1 + cells. 
On the basis of our family data, inheritance of NKB1  ex- 
pression phenotypes is complex, which further suggests it is 
controlled  by  several  factors.  The  frequency  of NKB1 § 
cells  observed  in  parents  and  children  is  not  readily ex- 
plained by simple patterns of Mendelian inheritance, since 
children can have values matching, intermediate between, 
or greater than those of the parents.  Inheritance of NKB1 
1825  Gumperz et al. cell surface expression level might be explained by a multi- 
allelic  codominant system that includes  a  null  allele.  Two 
samples (I31 and F2) are not completely consistent with this 
hypothesis,  because the  fluorescence intensity  of the  chil- 
dren  is  not  equivalent  to  that  of the  contributing parent. 
Hence,  further  analysis  will  be  required  to  clarify  how 
NKB1 expression phenotypes are inherited. 
Molecules  recognized by the  DX9 mAb are biochemi- 
cally and antigenically similar,  and NK cells with different 
levels  of NKB1  expression  have  yet  to  be  distinguished 
functionally.  Yet,  both  NKB1  frequency  and  expression 
level were stable  over 2  yr,  and  NKB1 +  NK and  T  cells 
from the  same  individual  have  similar  patterns  of expres- 
sion,  indicating  NKB1  expression  is  tightly  regulated 
within  an  individual.  The  extraordinary  heterogeneity  of 
NKB1 expression among individuals combined with its sta- 
bility  is  therefore  puzzling.  Important  questions  concern 
the influence of NKB1  expression on NK cell function in 
vivo, and whether expression patterns are maintained  dur- 
ing  viral  or bacterial  infections.  If NKB1  influences  the 
functional role of cells activated by infections by interacting 
with class I molecules, the presence or absence of potential 
class I ligands for NKB1  and individual phenotypes of ex- 
pression  could  be  of signifance  for  NK  and  T  cell  re- 
sponses. 
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